TABLE 3.
Ligand | [PTEN]/[PL] | τP-e | RP-e(0) | r6 × 1054 (m6) | rappa |
---|---|---|---|---|---|
ns | Å | ||||
diC6PI | 0.0016 | 172 ± 21 | 0.88 ± 0.05 | 3.80 ± 0.46 | 12.5 ± 0.3 |
diC6PI(4,5)P2 | 0.0017 | ||||
P-1 | 37 ± 18 | 0.19 ± 0.04 | 4.0 ± 2.1 | 12.6 ± 1.1 | |
P-4 | 35 ± 15 | 0.09 ± 0.01 | 8.0 ± 3.4 | 14.2 ± 1.1 | |
P-5 | 32 ± 9 | 0.11 ± 0.01 | 6.0 ± 1.7 | 13.5 ± 0.6 | |
diC8PIb | 0.0007 | 200a | 3.13 ± 0.36 | 0.54 ± 0.07 | 9.0 ± 0.2 |
diC8PI/Triton X-100 (1:2)cc | 0.0007 | 68 ± 10 | 1.12 ± 0.07 | 0.52 ± 0.08 | 9.0 ± 0.2 |
diC8PI(4,5)P2 | 0.0016 | ||||
P-1 | 128 ± 26 | 1.53 ± 0.15 | 1.6 ± 0.3 | 10.8 ± 0.4 | |
P-4 | 131 ± 18 | 0.52 ± 0.03 | 4.9 ± 0.7 | 13.0 ± 0.3 | |
P-5 | 99 ± 22 | 0.58 ± 0.06 | 3.3 ± 0.7 | 12.2 ± 0.4 | |
diC8PI/diC8PI(4,5)P2 | 0.0016 | ||||
P-1 | 103 ± 20 | 1.47 ± 0.13 | 1.4 ± 0.4 | 10.5 ± 0.4 | |
P-4 | 169 ± 21 | 0.45 ± 0.03 | 7.4 ± 0.4 | 14.0 ± 0.3 | |
P-5 | 153 ± 19 | 0.53 ± 0.03 | 5.7 ± 0.4 | 13.4 ± 0.3 | |
diC7PCd | 0.0011 | 120 ± 15 | 3.96 ± 0.24 | 0.40 ± 0.05 | 8.6 ± 0.2 |
diC7PC/Triton X-100 (1:2) | 0.0011 | 118 ± 17 | 1.68 ± 0.15 | 0.94 ± 0.13 | 9.9 ± 0.2 |
diC7PC/diC8PI(4,5)P2e | |||||
P-1/PC | 110 ± 13 | 1.79 ± 0.11 | |||
P-4 | 0.0018 | 93 ± 20 | 0.55 ± 0.03 | 3.7 ± 0.8 | 12.4 ± 0.4 |
P-5 | 0.0018 | 101 ± 25 | 0.68 ± 0.08 | 3.2 ± 0.8 | 12.2 ± 0.5 |
a rapp is the 31P-e distance computed if the PR1E is due to a single closest spin label, although not a real distance because other cysteines are spin-labeled, it does serve for comparing how different ligands bind.
b The data for diC8PI required fitting with two dispersions: for the slower one, the value of τP-e is 200 ns, and the value from the low field dispersion measured for the system with unlabeled PI-PLC was used for determining RP-e(0). Error in τ was estimated as ±50 ns.
c PI concentration was 3 mm.
d The dispersion for diC7PC was fit with a single τP-e.
e The sample contained 5 mm diC7PC and 3 mm diC8PI(4,5)P2; overlap of both phosphodiester resonances and similar relaxation profiles makes ascribing rapp6 to a particular phospholipid impossible.